✦ LIBER ✦

Olanzapine versus divalproex sodium for bipolar mania: a 47-week study

✍ Scribed by M. Tohen; R.W. Baker; L. Altshuler; C.A. Zarate; T. Suppes; T.A. Ketter; R.C. Risser; E. Brown; M.F. Luther; J.A. Gilmore; L. Schuh

Book ID: 119567917
Publisher: Elsevier Science
Year: 2002
Tongue: French
Weight: 125 KB
Volume: 17
Category: Article
ISSN: 0924-9338
DOI: 10.1016/s0924-9338(02)80488-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Olanzapine versus divalproex sodium for

Olanzapine versus divalproex sodium for bipolar mania in rapid cyclers

✍ R. Baker; M. Tohen; E. Brown; L. Schuh; C. Zarate Jr.; T. Suppes 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 119 KB

Olanzapine versus divalproex sodium for

Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: A 47-week study

✍ M. Tohen; R.W. Baker; L. Altshuler; C.A. Zarate; T. Suppes; T.A. Ketter; R. Riss 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 132 KB

Rapid versus non-rapid cycling as a pred

Rapid versus non-rapid cycling as a predictor of response to olanzapine and divalproex sodium for bipolar mania and maintenance of remission: Post hoc analyses of 47-week data

✍ Trisha Suppes; Eileen Brown; Leslie M. Schuh; Robert W. Baker; Mauricio Tohen 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 145 KB

P.2.f.002 Olanzapine versus divalproex a

P.2.f.002 Olanzapine versus divalproex and placebo for the treatment of mild to moderate mania associated with bipolar I disorder

✍ M. Tohen; E. Vieta; J. Jay Amsterdam; S.T. Aaronson; B. Sun; C. Bowden; M. Banov 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Safety and efficacy of olanzapine monoth

Safety and efficacy of olanzapine monotherapy in treatment-resistant bipolar mania: a 12-week open-label study

✍ Jun Chen; David J. Muzina; David E. Kemp; Carla Conroy; Philip Chan; Mary Beth S 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB

## Objective To examine the safety and efficacy of olanzapine monotherapy in treatment‐resistant bipolar mania. ## Method Subjects (__n__ = 18) who were acutely manic, did not respond to lithium, anticonvulsants, and neuroleptics, and/or had intolerable side effects to them in previous manic epis

PMH22 ECONOMIC OUTCOMES ASSOCIATED WITH

PMH22 ECONOMIC OUTCOMES ASSOCIATED WITH OLANZAPINE VERSUS DIVALPROEX TREATMENT FOR ACUTE MANIA: RESULTS FROM A RANDOMIZED CLINICAL TRIAL

✍ B Zhu; R Baker; L Altshuler; C Zarate; T Ketter; M Lage; S Tunis; L Shi; M Tohen 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB